591 related articles for article (PubMed ID: 26306935)
1. Pharmacologic overview of Withania somnifera, the Indian Ginseng.
Dar NJ; Hamid A; Ahmad M
Cell Mol Life Sci; 2015 Dec; 72(23):4445-60. PubMed ID: 26306935
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.
Mandlik Ingawale DS; Namdeo AG
J Diet Suppl; 2021; 18(2):183-226. PubMed ID: 32242751
[No Abstract] [Full Text] [Related]
3. Neurodegenerative diseases and Withania somnifera (L.): An update.
Dar NJ; MuzamilAhmad
J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
5. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
6. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
7. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic Withanolides from the Roots of Indian Ginseng ( Withania somnifera).
Kim S; Yu JS; Lee JY; Choi SU; Lee J; Kim KH
J Nat Prod; 2019 Apr; 82(4):765-773. PubMed ID: 30776236
[TBL] [Abstract][Full Text] [Related]
9. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
Paul S; Chakraborty S; Anand U; Dey S; Nandy S; Ghorai M; Saha SC; Patil MT; Kandimalla R; Proćków J; Dey A
Biomed Pharmacother; 2021 Nov; 143():112175. PubMed ID: 34649336
[TBL] [Abstract][Full Text] [Related]
10. Phytochemistry, Food Application, and Therapeutic Potential of the Medicinal Plant (
Khan MI; Maqsood M; Saeed RA; Alam A; Sahar A; Kieliszek M; Miecznikowski A; Muzammil HS; Aadil RM
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833974
[TBL] [Abstract][Full Text] [Related]
11. Phyto-therapeutic potential of Withania somnifera: Molecular mechanism and health implications.
Yadav N; Tripathi S; Sangwan NS
Phytother Res; 2024 Mar; 38(3):1695-1714. PubMed ID: 38318763
[TBL] [Abstract][Full Text] [Related]
12. Biotechnological interventions in Withania somnifera (L.) Dunal.
Singh P; Guleri R; Singh V; Kaur G; Kataria H; Singh B; Kaur G; Kaul SC; Wadhwa R; Pati PK
Biotechnol Genet Eng Rev; 2015; 31(1-2):1-20. PubMed ID: 25787309
[TBL] [Abstract][Full Text] [Related]
13. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
14. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug.
Hassannia B; Logie E; Vandenabeele P; Vanden Berghe T; Vanden Berghe W
Biochem Pharmacol; 2020 Mar; 173():113602. PubMed ID: 31404528
[TBL] [Abstract][Full Text] [Related]
15. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
17. Withania somnifera - a magic plant targeting multiple pathways in cancer related inflammation.
Kumar P; Sharma R; Garg N
Phytomedicine; 2022 Jul; 101():154137. PubMed ID: 35533610
[TBL] [Abstract][Full Text] [Related]
18. Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component.
Dar PA; Singh LR; Kamal MA; Dar TA
Curr Pharm Des; 2016; 22(5):535-40. PubMed ID: 26601969
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics of Withania somnifera (L.) Dunal: Advances and applications.
Tetali SD; Acharya S; Ankari AB; Nanakram V; Raghavendra AS
J Ethnopharmacol; 2021 Mar; 267():113469. PubMed ID: 33075439
[TBL] [Abstract][Full Text] [Related]
20. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
